Back & Body Extra Strength and Defibrotide Intravenous
Determining the interaction of Back & Body Extra Strength and Defibrotide Intravenous and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using defibrotide together with aspirin may increase the risk of bleeding. Talk to your doctor if you have any questions or concerns. Your doctor may already be aware of the risks, but has determined that this is the best course of treatment for you and has taken appropriate precautions and is monitoring you closely for any potential complications. You should seek immediate medical attention if you experience any unusual bleeding or bruising, or have other signs and symptoms of bleeding such as dizziness; lightheadedness; red or black, tarry stools; coughing up or vomiting fresh or dried blood that looks like coffee grounds; severe headache; and weakness. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR CLOSELY: Coadministration of defibrotide with antiplatelet agents or other agents that affect coagulation may increase the risk of bleeding. In vitro, defibrotide increased the activity of fibrinolytic enzymes. In a mouse model of thromboembolism, recombinant tissue plasminogen activator (t-PA) potentiated the antithrombotic effect of defibrotide when given intravenously.
MANAGEMENT: Concomitant use of medications that interfere with platelet function or coagulation should be considered cautiously in patients treated with defibrotide. Close clinical and laboratory observation for bleeding complications is recommended during therapy. If bleeding develops, defibrotide should be discontinued and treatment/supportive care provided until the bleeding stops.
- "Product Information. Defitelio (defibrotide)." Jazz Pharmaceuticals, Palo Alto, CA.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Generic Name: aspirin / caffeine
Brand name: Back & Body Extra Strength, Bayer Back & Body Pain Extra Strength, Cope, CVS Back & Body, P-A-C, Alka-Seltzer Morning Relief, Anacin, Bayer Back & Body, BC Arthritis, P-A-C Analgesic, Stanback, Aspircaf, Genasan, Adult Strength, Midol Traditional, Anacin Extra Strength, BC, BC Fast Pain Relief
Synonyms: n.a.
Generic Name: defibrotide
Brand name: Defitelio
Synonyms: Defibrotide, Defibrotide Sodium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Back & Body Extra Strength-Defibrotide Sodium
- Back & Body Extra Strength-Definity
- Back & Body Extra Strength-Defitelio
- Back & Body Extra Strength-Deflazacort
- Back & Body Extra Strength-Deflazacort Oral Suspension
- Back & Body Extra Strength-Deflazacort Tablets
- Defibrotide Intravenous-Backaid IPF
- Defibrotide Intravenous-Baclofen
- Defibrotide Intravenous-Baclofen Injection
- Defibrotide Intravenous-Baclofen Intrathecal
- Defibrotide Intravenous-Baclofen Intrathecal Injection
- Defibrotide Intravenous-Baclofen Oral Solution